Literature DB >> 17465448

Iron deposition and fat accumulation in dimethylnitrosamine-induced liver fibrosis in rat.

Jin-Yang He1, Wen-Hua Ge, Yuan Chen.   

Abstract

AIM: To investigate if iron deposition and fat accumulation in the liver play a pathogenetic role in dimethylnitrosamine (DMN)-induced liver fibrosis in rat.
METHODS: Thirty rats were treated with DMN at does consecutive days of 10 microL/kg daily, i.p., for 3 consecutive day each week for 4 wk. Rats (n=30) were sacrificed on the first day (model group A) and 21(st) d (model group B) after cessation of DMN injection. The control group (n=10) received an equivalent amount of saline. Liver tissues were stained with hematoxylin and eosin (HE) and Masson and Prussian blue assay and observed under electron microscopy. Serum alanine aminotransferase (ALT) and liver tissue hydroxyproline (Hyp) content were tested.
RESULTS: The liver fibrosis did not automatically reverse, which was similar to previous reports, the perilobular deposition of iron accompanied with collagen showed marked characteristics at both the first and 21(st) d after cessation of DMN injection. However, fat accumulation in hepatocytes occurred only at the 21(st) d after cessation of DMN injection.
CONCLUSION: Iron deposition and fat accumulation may play important roles in pathological changes in DMN-induced rat liver fibrosis. The detailed mechanisms of these characteristics need further research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465448      PMCID: PMC4319125          DOI: 10.3748/wjg.v13.i14.2061

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Dietary iron overload inhibits carbon tetrachloride-induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation.

Authors:  G S Wang; L C Eriksson; L Xia; J Olsson; P Stål
Journal:  J Hepatol       Date:  1999-04       Impact factor: 25.083

2.  HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.

Authors:  Andreas Erhardt; Andrea Maschner-Olberg; Claudia Mellenthin; Günther Kappert; Ortwin Adams; Andreas Donner; Reinhard Willers; Claus Niederau; Dieter Häussinger
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

3.  Effects of alcohol, carbon tetrachloride, and choline deficiency on iron metabolism in the rat.

Authors:  R G Batey; R Johnston
Journal:  Alcohol Clin Exp Res       Date:  1993-10       Impact factor: 3.455

4.  Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells.

Authors:  G Svegliati-Baroni; S Saccomanno; H van Goor; P Jansen; A Benedetti; H Moshage
Journal:  Liver       Date:  2001-02

5.  Hepatitis C, iron status, and disease severity: relationship with HFE mutations.

Authors:  Bruce Y Tung; Mary J Emond; Mary P Bronner; Stuart D Raaka; Scott J Cotler; Kris V Kowdley
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

6.  Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism.

Authors:  A M Jézéquel; R Mancini; M L Rinaldesi; G Ballardini; M Fallani; F Bianchi; F Orlandi
Journal:  J Hepatol       Date:  1989-01       Impact factor: 25.083

Review 7.  Iron and the liver.

Authors:  Elena Corradini; Francesca Ferrara; Antonello Pietrangelo
Journal:  Pediatr Endocrinol Rev       Date:  2004-12

8.  Iron overload enhances the development of experimental liver cirrhosis in mice.

Authors:  Beatrice Arezzini; Benedetta Lunghi; Giuseppe Lungarella; Concetta Gardi
Journal:  Int J Biochem Cell Biol       Date:  2003-04       Impact factor: 5.085

9.  A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat.

Authors:  A M Jézéquel; R Mancini; M L Rinaldesi; G Macarri; C Venturini; F Orlandi
Journal:  J Hepatol       Date:  1987-10       Impact factor: 25.083

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  4 in total

1.  San-Cao Granule () Ameliorates Hepatic Fibrosis through High Mobility Group Box-1 Protein/Smad Signaling Pathway.

Authors:  Shi-Zhang Wei; Sheng-Qiang Luo; Jian Wang; Jia-Bo Wang; Rui-Sheng Li; Xiao-Mei Zhang; Yan-Lei Guo; Chang Chen; Xiao Ma; Zhe Chen; Hong-Hong Liu; Zhi-Rui Yang; Jian-Yu Li; Rui-Lin Wang; Ya-Ming Zhang; Hui-Yin Yang; Xiao-He Xiao; Yan-Ling Zhao
Journal:  Chin J Integr Med       Date:  2015-12-19       Impact factor: 1.978

2.  Supplementation of fresh ucche (Momordica charantia L. var. muricata Willd) prevented oxidative stress, fibrosis and hepatic damage in CCl4 treated rats.

Authors:  Abu Taher Sagor; Mohammed Riaz Hasan Chowdhury; Nabila Tabassum; Hemayet Hossain; Md Mahbubur Rahman; Md Ashraful Alam
Journal:  BMC Complement Altern Med       Date:  2015-04-11       Impact factor: 3.659

3.  A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis.

Authors:  Shizhang Wei; Ming Niu; Jian Wang; Jiabo Wang; Haibin Su; Shengqiang Luo; Xiaomei Zhang; Yanlei Guo; Liping Liu; Fengqun Liu; Qingguo Zhao; Hongge Chen; Xiaohe Xiao; Pan Zhao; Yanling Zhao
Journal:  Drug Des Devel Ther       Date:  2016-02-19       Impact factor: 4.162

4.  A new style of dimethylnitrosamine induced fulminant hepatitis in mice.

Authors:  Hanping Liu; Qingya Li; Hong Liu; Yuansheng Wu; Jinyang He
Journal:  Hepat Mon       Date:  2013-09-14       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.